Artiva Biotherapeutics (ARTV) Profit After Tax (2023 - 2026)
Artiva Biotherapeutics (ARTV) reported Profit After Tax of -$23.5 million for Q1 2026, down 15.78% year-over-year from -$27.9 million in Q1 2025, and down 13.21% quarter-over-quarter from -$20.8 million in Q4 2025.
Artiva Biotherapeutics (ARTV) Profit After Tax (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of Profit After Tax data on file, last reported at -$23.5 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$23.5 million, down 15.78% year-over-year; the trailing twelve-month figure through Mar 2026 was -$87.1 million (down 21.4% YoY), and the FY2025 annual result was -$83.9 million, down 28.29% from the prior year.
- Profit After Tax fell to -$23.5 million in Q1 2026 per ARTV's latest filing, from -$20.8 million in the prior quarter.
- Over five years, Profit After Tax peaked at $11.3 million in Q3 2023 and troughed at -$23.5 million in Q1 2026.
- A 4-year average of -$15.4 million and a median of -$17.7 million in 2024 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2024 and 2026: Profit After Tax sank 254.91% in 2024, then retreated 15.78% in 2026.
- A 4-year view of Profit After Tax shows it stood at -$12.0 million in 2023, then sank by 34.15% to -$16.1 million in 2024, then fell by 29.06% to -$20.8 million in 2025, then fell by 13.21% to -$23.5 million in 2026.
- Business Quant data shows ARTV's Profit After Tax at -$23.5 million in Q1 2026, -$20.8 million in Q4 2025, and -$21.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Artiva Biotherapeutics | 241.85 Mn | 241.85 Mn | - | -23.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.52 Mn |
| Dec 31, 2025 | -20.77 Mn |
| Sep 30, 2025 | -21.53 Mn |
| Jun 30, 2025 | -21.25 Mn |
| Mar 31, 2025 | -20.31 Mn |
| Dec 31, 2024 | -16.10 Mn |
| Sep 30, 2024 | -17.47 Mn |
| Jun 30, 2024 | -17.84 Mn |
| Mar 31, 2024 | -13.96 Mn |
| Dec 31, 2023 | -12.00 Mn |
| Sep 30, 2023 | 11.28 Mn |
| Jun 30, 2023 | -11.28 Mn |